Bristol Myers Squibb and Celgene named in class action suit over cancer blockbuster Pomalyst
Blue Cross Blue Shield of Louisiana is taking Bristol Myers Squibb to court over what it alleges to be an unlawful monopoly for the cancer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
